Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy

Homocysteine is an independent risk factor for cardiovascular and cerebrovascular disease and has been proposed to contribute to vascular dysfunction. We sought to determine in a real‐world clinical setting whether homocysteine levels were associated with hypertension mediated organ damage (HMOD) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnagarin, Revathy, Nolde, Janis M., Ward, Natalie C., Lugo‐Gavidia, Leslie Marisol, Chan, Justine, Robinson, Sandi, Jose, Ancy, Joyson, Anu, Azzam, Omar, Galindo Kiuchi, Márcio, Mwipatayi, Bibombe P., Schlaich, Markus P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Homocysteinemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678735/
https://www.ncbi.nlm.nih.gov/pubmed/34137162
http://dx.doi.org/10.1111/jch.14265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678735/
https://www.ncbi.nlm.nih.gov/pubmed/34137162
http://dx.doi.org/10.1111/jch.14265

Ejemplares similares